| Literature DB >> 28225790 |
Ali Safarnejad1, Jose-Antonio Izazola-Licea2.
Abstract
BACKGROUND: An enabling environment is believed to have significant and critical effects on HIV and AIDS program implementation and desired outcomes. This paper estimates the paths, directionality, and direct and indirect associations between critical enablers with antiretroviral treatment (ART) coverage and to AIDS-related mortality.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28225790 PMCID: PMC5321283 DOI: 10.1371/journal.pone.0172569
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Constructs considered in conceptual model, corresponding variables of their measurement, data sources, and decisions with respect to inclusion of variable in the model.
| Construct | Related Variables | Data Source |
|---|---|---|
| ART Retention | UNAIDS: | |
| HIV Prevalence | Global report: UNAIDS report on the global AIDS epidemic 2013. Annex: Pp A3-A9. UNAIDS: Geneva, 2013 | |
| Human Rights and Anti-Discrimination | OHCHR: | |
| Financing | UNAIDS: | |
| Gender | UNDP: UNAIDS: | |
| Governance | Voice and Accountability | The World Bank: |
| Health Workforce | Number of nursing personnel and physicians per 1,000 people | WHO: |
| HIV Testing & Counseling | WHO: | |
| Human Development | Mortality rate, infant (per 1,000 live births) | UNDP: |
| Legal Environment | UNAIDS: | |
| ART | WHO: | |
| Logistics | The efficiency of customs and border management clearance (“Customs”) | The World Bank: |
| Mortality Rate | UNAIDS: | |
| Testing Service Delivery | WHO: | |
| Social/Financial Protection | WHO: | |
| Stigma / Homophobia | ILGA: Stigma Index: | |
| TB | Co-Management of TB and HIV Treatment | UNAIDS: |
Notes.
The variables actually included in the final model are highlighted in bold format.
* Construct from Health Systems Framework
+ Construct from Investment Framework
# Construct from Proximate-Determinants Framework
a. Variable failed to group during cluster analysis
b. Variable not used in model due to low significance of effect
c. Variable not considered due to small sample size
d. Variable rejected in factor analysis
e. Inclusion of variable reduces the overall fit of the model
Constructs of the structural model, corresponding variables and year of their measurement.
| Construct | Method of Measurement | Year(s) |
|---|---|---|
| AIDS Mortality | Number of AIDS Related Deaths per Number of people living with HIV (all ages) | 2012 |
| Anti-Discrimination Conventions | Ordinal measure variables constructed from five indicators: ICCPR, ICESCR, ICERD, CEDAW, CRC (see | 2013 |
| ART Coverage | Percentage of eligible adults and children currently receiving Antiretroviral therapy based on WHO 2010 guidelines | 2011 |
| Commitment to Anti-Discrimination Conventions | Total number of reports submitted on ICCPR, ICESCR, ICERD, CEDAW, and CRC. All measures are from year of ratification of convention to present time. | 2014 |
| Domestic AIDS Spending | Domestic Public Expenditure on AIDS from Public Sources per USD 1,000 of Total Health Expenditure | 2011 |
| Gender Inequality Index | Gender Inequality Index | 2012 |
| Gender Visibility Scorecard | Ordinal measure variables constructed from nine indicators of the Gender Scorecard: 1) Disaggregated Data; 2) Qualitative Assessments; 3) Data on National Responses for Women’s Programmes; 4) SRH-HIV integration; 5) Health Sector GBV Policy; 6) HIV plans/budgets in women ministries; 7) HIV+ women participation in response review; 8) Affected women participation in CEDAW monitoring; 9) Social protection for +women. Values assigned are 2: Present at National Level, 1: Available on Project Basis, 0: Not Available. Mean of un-weighted linear sum of variables is taken as a continuous measure on Gender Visibility Scorecard. | |
| Governance | Latent variable factored together from four indicators: 1) Regulatory Quality; 2) Control of Corruption; 3) Rule of Law; 4) Government Effectiveness; | 2012 |
| HIV Prevalence | Estimated number of people living with HIV per total population | 2012 |
| HIV Testing & Counseling | Number who received HIV Testing and Counseling (>15 years) per 1000 people | 2010 |
| Human Development Index | Human Development Index | 2012 |
| Logistics | Latent variable factored together from six indicators: 1) Customs; 2) Infrastructure; 3) International shipments; 4) Timeliness; 5) Tracking and tracing; 6) Logistics competence; | 2012 |
| Punitive Laws & Homophobia | Index constructed from five themes of the legal environment: 1) Laws that specifically criminalize HIV transmission or exposure; 2) Laws deeming sex work («prostitution») to be illegal; 3) Laws that impose compulsory treatment for people who use drugs and/or provide for death penalty for drug offences; 4) Laws, regulations or policies that present obstacles to access to prevention, treatment, care and support for vulnerable subpopulations; 5) Legal situation of lesbian, gay, bisexual and trans people («comparative homophobia index»). Each element of the index given a score of 1 or -1 based on existence of laws or policies that act as enablers or barriers respectively. A special value of -2 given to States that exercise the death penalty for drug offences. The index is the mean of un-weighted linear sum of the individual theme scores. | 2010 (homo-phobia index from 2012) |
| Retention on ART | Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy | 2011–2012 |
| Social/Financial Protection | Out of pocket expenditure on health (in current US$ per capita) per GNI per Capita (Atlas Method) | 2011 |
| Testing Service Delivery | Estimated number of facilities in the country providing HIV testing and counseling, per 100,000 population | 2010 |
Countries, income groups, and regions with complete data included in the analysis.
| Country | Income Group | Region | HIV Prevalence (%) Adults 15–49 (2012) |
|---|---|---|---|
| Afghanistan | Low | Asia and the Pacific | <0.1 (<0.1–<0.1) |
| Angola | Lower–middle | Sub-Saharan Africa | 2.3 (1.9–2.8) |
| Armenia | Lower–middle | Eastern Europe and Central Asia | 0.2 (0.2–0.3) |
| Belarus | Lower–middle | Eastern Europe and Central Asia | 0.4 (0.4–0.5) |
| Benin | Low | Sub-Saharan Africa | 1.1 (1.0–1.3) |
| Bolivia | Lower–middle | Latin America and the Caribbean | 0.3 (0.1–0.4) |
| Botswana | Upper–middle | Sub-Saharan Africa | 23.0 (21.8–24.4) |
| Burundi | Low | Sub-Saharan Africa | 1.3 (1.0–1.5) |
| Côte d'Ivoire | Low | Sub-Saharan Africa | 0.8 (0.5–1.5) |
| Cambodia | Low | Asia and the Pacific | 4.5 (4.1–4.9) |
| Cameroon | Lower–middle | Sub-Saharan Africa | 2.8 (2.5–3.0) |
| Congo | Low | Sub-Saharan Africa | 3.2 (2.8–3.8) |
| DR Congo | Low | Sub-Saharan Africa | 0.7 (0.6–0.8) |
| Dominican Republic | Lower–middle | Latin America and the Caribbean | 1.1 (1.0–1.2) |
| Ecuador | Lower–middle | Latin America and the Caribbean | 0.6 (0.4–1.1) |
| Egypt | Lower–middle | Middle East and North Africa | <0.1 (<0.1–<0.1) |
| Ethiopia | Low | Sub-Saharan Africa | 1.3 (1.2–1.5) |
| Fiji | Lower–middle | Asia and the Pacific | 0.2 (0.2–0.2) |
| Gambia | Low | Sub-Saharan Africa | 1.3 (0.9–1.7) |
| Georgia | Lower–middle | Eastern Europe and Central Asia | 0.3 (0.2–0.4) |
| Ghana | Low | Sub-Saharan Africa | 1.4 (1.2–1.6) |
| Guatemala | Lower–middle | Latin America and the Caribbean | 0.7 (0.4–1.5) |
| Guinea-Bissau | Low | Sub-Saharan Africa | 3.9 (2.9–5.3) |
| Guyana | Lower–middle | Latin America and the Caribbean | 1.3 (0.8–2.1) |
| Haiti | Low | Latin America and the Caribbean | 2.1 (1.9–2.3) |
| Honduras | Lower–middle | Latin America and the Caribbean | 0.5 (0.4–0.7) |
| Indonesia | Lower–middle | Asia and the Pacific | 0.4 (0.3–0.7) |
| Iran | Lower–middle | Middle East and North Africa | 0.2 (0.1–0.2) |
| Kenya | Low | Sub-Saharan Africa | 6.1 (5.9–6.3) |
| PDR Lao | Low | Asia and the Pacific | 23.1 (21.7–24.7) |
| Lesotho | Lower–middle | Sub-Saharan Africa | 0.9 (0.7–1.1) |
| Liberia | Low | Sub-Saharan Africa | 10.8 (10.2–11.4) |
| Malawi | Low | Sub-Saharan Africa | 0.4 (0.3–0.6) |
| Malaysia | Upper–middle | Asia and the Pacific | <0.1 (<0.1–<0.1) |
| Maldives | Lower–middle | Asia and the Pacific | 1.2 (1.2–1.3) |
| Mauritius | Upper–middle | Sub-Saharan Africa | 0.7 (0.6–0.9) |
| Moldova | Lower–middle | Eastern Europe and Central Asia | 0.1 (0.1–0.2) |
| Morocco | Lower–middle | Middle East and North Africa | 0.3 (0.2–0.4) |
| Nepal | Low | Asia and the Pacific | 0.5 (0.4–0.6) |
| Niger | Low | Sub-Saharan Africa | 3.1 (2.8–3.5) |
| Nigeria | Low | Sub-Saharan Africa | 0.5 (0.4–0.7) |
| Papua New Guinea | Low | Asia and the Pacific | 0.3 (0.2–0.6) |
| Paraguay | Lower–middle | Latin America and the Caribbean | 0.3 (0.2–0.3) |
| Peru | Lower–middle | Latin America and the Caribbean | 0.4 (0.2–1.3) |
| Philippines | Lower–middle | Asia and the Pacific | <0.1 (<0.1–<0.1) |
| Rwanda | Low | Sub-Saharan Africa | 2.9 (2.6–3.2) |
| Sao Tome & Principe | Low | Sub-Saharan Africa | 1.0 (0.8–1.4) |
| Sierra Leone | Low | Sub-Saharan Africa | 1.5 (1.0–2.1) |
| South Africa | Upper–middle | Sub-Saharan Africa | 17.9 (17.3–18.4) |
| Sri Lanka | Lower–middle | Asia and the Pacific | <0.1 (<0.1–<0.1) |
| Tajikistan | Low | Eastern Europe and Central Asia | 0.3 (0.2–0.6) |
| Tanzania | Low | Sub-Saharan Africa | 5.1 (4.6–5.7) |
| Thailand | Lower–middle | Asia and the Pacific | 1.1 (1.0–1.2) |
| Togo | Low | Sub-Saharan Africa | 2.9 (2.5–3.5) |
| Tunisia | Lower–middle | Middle East and North Africa | <0.1 (<0.1–<0.1) |
| Ukraine | Lower–middle | Eastern Europe and Central Asia | 0.9 (0.7–1.0) |
| Uzbekistan | Low | Eastern Europe and Central Asia | 0.2 (0.2–0.2) |
| Viet Nam | Low | Asia and the Pacific | 0.4 (0.1–0.8) |
| Yemen | Low | Middle East and North Africa | 0.1 (<0.1–0.3) |
Fig 1Measurement model for latent variables with standardized estimates.
Diagram Elements: Boxes are manifest (observed) variables; Circles are latent (unobserved) constructs; Straight arrows point from latent constructs to measurement variables; Curved arrows are unexplained covariance among variables; δ (small delta) are residual variances of the observed variables; Values are standardized regression coefficients and number of stars signify their p-value: * p <.1; ** p <.05;*** p <.01.
Fig 2Structural equation model specifying key relationships between enablers, program activities, and outcome with standardized coefficients.
Diagram Elements: Boxes are manifest (observed) variables; Circles are latent (unobserved) constructs; Arrows point from explanatory variable to dependent variable; Values are standardized regression coefficients and number of stars signify their p-value: * p <.1; ** p <.05; *** p <.01.
Standardized effect of constructs on ART coverage derived by structural equation modeling.
| Variable | Standardized Coefficient | p-value |
|---|---|---|
| Social/Financial Protection | -0.319 | 0.001 |
| Governance | 0.313 | 0.002 |
| Domestic AIDS Spending | 0.31 | <0.001 |
| HIV Testing & Counseling | 0.274 | 0.009 |
| ART Retention | 0.257 | 0.007 |
| Anti-discrimination Conventions | 0.246 | 0.017 |
| Gender Visibility Scorecard Index | 0.217 | 0.085 |
| Testing Service Delivery (HTC Facilities) | 0.148 | 0.028 |
| Human Development Index | -0.076 | 0.056 |
| Commitment to Anti-Discrimination | 0.072 | 0.123 |
| Punitive Laws & Homophobia | 0.047 | 0.123 |
| Logistics | -0.023 | 0.100 |